An evaluation of memantine ER + donepezil for the treatment of Alzheimer’s disease
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
An evaluation of memantine ER + donepezil for the treatment of Alzheimer’s disease
Authors
Keywords
-
Journal
EXPERT OPINION ON PHARMACOTHERAPY
Volume -, Issue -, Pages 1-7
Publisher
Informa UK Limited
Online
2018-09-23
DOI
10.1080/14656566.2018.1519022
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- 2018 Alzheimer's disease facts and figures
- (2018) Alzheimers & Dementia
- Changing Paradigm from one Target one Ligand Towards Multi-target Directed Ligand Design for Key Drug Targets of Alzheimer Disease: An Important Role of In Silico Methods in Multi-target Directed Ligands Design
- (2018) Akhil Kumar et al. Current Neuropharmacology
- Effect of Idalopirdine as Adjunct to Cholinesterase Inhibitors on Change in Cognition in Patients With Alzheimer Disease
- (2018) Alireza Atri et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- The State of US Health, 1990-2016
- (2018) et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Novel multi-target directed ligand-based strategies for reducing neuroinflammation in Alzheimer's disease
- (2018) Tyler Joseph Wenzel et al. LIFE SCIENCES
- Discontinuation, Efficacy, and Safety of Cholinesterase Inhibitors for Alzheimer’s Disease: a Meta-Analysis and Meta-Regression of 43 Randomized Clinical Trials Enrolling 16 106 Patients
- (2017) Lídia Blanco-Silvente et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Treatment effects between monotherapy of donepezil versus combination with memantine for Alzheimer disease: A meta-analysis
- (2017) Ruey Chen et al. PLoS One
- A systematic review of medication non-adherence in persons with dementia or cognitive impairment
- (2017) Daisy Smith et al. PLoS One
- Adamantane – A Lead Structure for Drugs in Clinical Practice
- (2016) Katarina Spilovska et al. CURRENT MEDICINAL CHEMISTRY
- A fixed-dose combination of memantine extended-release and donepezil in the treatment of moderate-to-severe Alzheimer’s disease
- (2016) William James Deardorff et al. Drug Design Development and Therapy
- Implications of GABAergic Neurotransmission in Alzheimer’s Disease
- (2016) Yanfang Li et al. Frontiers in Aging Neuroscience
- ASS234, As a New Multi-Target Directed Propargylamine for Alzheimer's Disease Therapy
- (2016) José Marco-Contelles et al. Frontiers in Neuroscience
- A Novel Once-Daily Fixed-Dose Combination of Memantine Extended Release and Donepezil for the Treatment of Moderate to Severe Alzheimer’s Disease: Two Phase I Studies in Healthy Volunteers
- (2015) Ramesh Boinpally et al. CLINICAL DRUG INVESTIGATION
- EFNS-ENS/EAN Guideline on concomitant use of cholinesterase inhibitors and memantine in moderate to severe Alzheimer's disease
- (2015) R. Schmidt et al. EUROPEAN JOURNAL OF NEUROLOGY
- Combination Therapy with Cholinesterase Inhibitors and Memantine for Alzheimer’s Disease: A Systematic Review and Meta-Analysis
- (2015) Shinji Matsunaga et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Nursing home placement in the Donepezil and Memantine in Moderate to Severe Alzheimer's Disease (DOMINO-AD) trial: secondary and post-hoc analyses
- (2015) Robert Howard et al. LANCET NEUROLOGY
- Multi-Target-Directed Ligands and other Therapeutic Strategies in the Search of a Real Solution for Alzheimer’s Disease
- (2014) Angel Agis-Torres et al. Current Neuropharmacology
- The Safety, Tolerability, and Efficacy of Once-Daily Memantine (28 mg): A Multinational, Randomized, Double-Blind, Placebo-Controlled Trial in Patients with Moderate-to-Severe Alzheimer’s Disease Taking Cholinesterase Inhibitors
- (2013) George T. Grossberg et al. CNS DRUGS
- A population-based study of dosing and persistence with anti-dementia medications
- (2013) Linda Brewer et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- A randomized, double-blind, placebo-controlled trial of memantine in a behaviorally enriched sample of patients with moderate-to-severe Alzheimer's disease
- (2013) Nathan Herrmann et al. INTERNATIONAL PSYCHOGERIATRICS
- Memantine and Cholinesterase Inhibitors: Complementary Mechanisms in the Treatment of Alzheimer’s Disease
- (2013) Chris G. Parsons et al. NEUROTOXICITY RESEARCH
- Monetary Costs of Dementia in the United States
- (2013) Michael D. Hurd et al. NEW ENGLAND JOURNAL OF MEDICINE
- Memantine in patients with Alzheimer's disease receiving donepezil: new analyses of efficacy and safety for combination therapy
- (2013) Alireza Atri et al. Alzheimers Research & Therapy
- Benefits of combined cholinesterase inhibitor and memantine treatment in moderate–severe Alzheimer's disease
- (2012) Serge Gauthier et al. Alzheimers & Dementia
- Medication Adherence in Older Adults With Cognitive Impairment: A Systematic Evidence-Based Review
- (2012) Noll L. Campbell et al. American Journal Geriatric Pharmacotherapy
- Evaluation and management of oropharyngeal dysphagia in different types of dementia: A systematic review
- (2012) Kannayiram Alagiakrishnan et al. ARCHIVES OF GERONTOLOGY AND GERIATRICS
- Alzheimer's disease, β-amyloid, glutamate, NMDA receptors and memantine - searching for the connections
- (2012) Wojciech Danysz et al. BRITISH JOURNAL OF PHARMACOLOGY
- Risk factors for medication nonadherence in older adults with cognitive impairment who live alone
- (2012) Thulasi Thiruchselvam et al. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY
- Donepezil and Memantine for Moderate-to-Severe Alzheimer's Disease
- (2012) Robert Howard et al. NEW ENGLAND JOURNAL OF MEDICINE
- Memantine and cholinesterase inhibitor combination therapy for Alzheimer's disease: a systematic review
- (2012) Lucy E Farrimond et al. BMJ Open
- Multi-Target-Directed Ligands in Alzheimer's Disease Treatment
- (2011) M. Bajda et al. CURRENT MEDICINAL CHEMISTRY
- Dementia Medications and Risk of Falls, Syncope, and Related Adverse Events: Meta-Analysis of Randomized Controlled Trials
- (2011) Dae Hyun Kim et al. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
- Predictors of adherence among Alzheimer's disease patients receiving oral therapy
- (2010) Bijan Borah et al. CURRENT MEDICAL RESEARCH AND OPINION
- Factors associated with persistence of cholinesterase inhibitor treatments in the elderly
- (2010) Antoine Pariente et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Syncope and Its Consequences in Patients With Dementia Receiving Cholinesterase Inhibitors
- (2009) Sudeep S. Gill et al. ARCHIVES OF INTERNAL MEDICINE
- Long-term effects of the concomitant use of memantine with cholinesterase inhibition in Alzheimer disease
- (2009) O L Lopez et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Cholinesterase Inhibitors and Incidence of Bradycardia in Patients with Dementia in the Veterans Affairs New England Healthcare System
- (2009) Rohini K. Hernandez et al. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
- Long-term Course and Effectiveness of Combination Therapy in Alzheimer Disease
- (2008) Alireza Atri et al. ALZHEIMER DISEASE & ASSOCIATED DISORDERS
- Memantine Treatment in Patients with Mild to Moderate Alzheimers Disease Already Receiving a Cholinesterase Inhibitor: A Randomized, Double-Blind, Placebo-Controlled Trial
- (2008) Anton Porsteinsson et al. Current Alzheimer Research
- Memantine for the Treatment of Alzheimer???s Disease
- (2008) Martin R Farlow et al. DRUG SAFETY
- 5-HT6 receptor antagonists as novel cognitive enhancing agents for Alzheimer’s disease
- (2008) Neil Upton et al. Neurotherapeutics
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started